The US DOJ memo outlines fraud enforcement priorities, spotlighting healthcare, tax, trade, and corporate misconduct.
DOJ
Split ruling reinstates DOJ subpoena to gender‑affirming care provider, finding the administration may pursue investigations consistent with its policy agenda.
Our in-brief roundup of notable healthcare and life sciences stories from the last two weeks.
The DOJ’s Antitrust Division is returning to targeted Second Request investigations.
The rules would let banks share some sensitive information without prior OCC approval.
Our in-brief roundup of notable healthcare and life sciences stories from the last two weeks.
The Justice Department’s Corporate Enforcement Policy offers declinations for companies that self disclose misconduct and cooperate with investigators.
By voluntarily self-disclosing the violations and cooperating with the DOJ, the testing laboratory avoided open-ended exposure, a corporate integrity agreement, and exclusion from federal programs.